Get the Stockscreener App
43.92
1.70%
-0.76
After Hours:
43.96
0.04
+0.09%
Boston Scientific Corp stock is traded at $43.92, with a volume of 14.99M.
It is down -1.70% in the last 24 hours and down -11.91% over the past month.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
See More
Previous Close:
$44.68
Open:
$44.68
24h Volume:
14.99M
Relative Volume:
0.73
Market Cap:
$63.65B
Revenue:
$20.62B
Net Income/Loss:
$3.56B
P/E Ratio:
18.42
EPS:
2.3847
Net Cash Flow:
$3.48B
1W Performance:
+1.34%
1M Performance:
-11.91%
6M Performance:
-37.06%
1Y Performance:
-55.25%
1-Day Range:
$43.33
$44.84
1-Week Range:
$42.72
$45.74
52-Week Range:
$42.20
$105.65
Boston Scientific Corp Stock (BSX) Company Profile
Name
Boston Scientific Corp
Sector
Industry
Phone
508-683-4000
Address
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, MDT, SYK, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
43.92 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
ABT
Abbott Laboratories
|
101.29 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
88.64 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
272.36 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
EW
Edwards Lifesciences Corp
|
86.29 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-30-26 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-03-25 | Downgrade | Erste Group | Buy → Hold |
| Sep-08-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Jun-16-25 | Initiated | Leerink Partners | Outperform |
| Apr-16-25 | Upgrade | Needham | Hold → Buy |
| Jan-10-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Oct-18-24 | Downgrade | Needham | Buy → Hold |
| May-30-24 | Initiated | Goldman | Buy |
| Feb-01-24 | Upgrade | Mizuho | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-22-22 | Initiated | Mizuho | Neutral |
| Dec-20-22 | Resumed | Citigroup | Buy |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-06-22 | Initiated | Wolfe Research | Outperform |
| May-27-22 | Upgrade | Needham | Hold → Buy |
| Apr-13-22 | Resumed | Truist | Buy |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| May-26-21 | Downgrade | Needham | Buy → Hold |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Sep-17-20 | Initiated | Truist | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-22-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-01-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Buy |
| Dec-30-19 | Reiterated | Cowen | Outperform |
| Dec-19-19 | Downgrade | Needham | Strong Buy → Buy |
| Sep-05-19 | Resumed | JP Morgan | Overweight |
| Sep-03-19 | Resumed | Barclays | Overweight |
| May-13-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Oct-02-18 | Reiterated | Morgan Stanley | Overweight |
| Sep-07-18 | Reiterated | Needham | Strong Buy |
| Sep-04-18 | Upgrade | Jefferies | Hold → Buy |
| Jul-06-18 | Reiterated | Needham | Strong Buy |
| Jun-27-18 | Initiated | Bernstein | Outperform |
| Apr-26-18 | Reiterated | Needham | Strong Buy |
View All
Boston Scientific Corp Stock (BSX) Latest News
Boston Scientific re-evaluates 2027 framework after cyberattack - scanx.trade
Boston Scientific Corp. stock underperforms Friday when compared to competitors - MarketWatch
Boston Scientific stock gains 2.06 percent ahead of the open - ad-hoc-news.de
Boston Scientific stock faces a weaker 2026 growth outlook - ad-hoc-news.de
Mexico Cardiac Rhythm Management Devices Market Outlook to 2036 Provides Revenue, Volume, Pricing and Competitive Insig - GlobeNewswire Inc.
Wells Fargo Adjusts Price Target on Boston Scientific to $48 From $50, Keeps Equalweight Rating - marketscreener.com
Boston Scientific stock slips before the bell after September 23 decline - ad-hoc-news.de
Boston Scientific (BSX) Executive VP Arthur C. Butcher to Retire in January 2027 - GuruFocus
Boston Scientific (NYSE: BSX) Announces Arthur C. Butcher's Retirement with $780,000 Base Salary as Senior Advisor - Kalkine Media
Boston Scientific Corporation Announces Retirement of Arthur C. Butcher from Executive Vice President and Group President, Medsurg and Asia Pacific, Effective January 1, 2027 - marketscreener.com
Form 8K Boston Scientific Corp For: 23 September By Investing.com - ng.investing.com
Boston Scientific announces retirement of executive vice president Arthur C. Butcher - Investing.com
Form 8K Boston Scientific Corp For: 23 September - Investing.com India
Arthur C. Butcher to Retire as Executive VP & Group President at Boston Scientific - TradingView
Boston Scientific stock advances 2.1 percent ahead of the open - ad-hoc-news.de
Boston Scientific (BSX) Stock Moves 2.74%: What You Should Know - finance.yahoo.com
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Boston Scientific stock holds near its yearly low after downgrade - ad-hoc-news.de
What Boston Scientific (BSX) Tells Us About the Healthcare Stocks Trade Right Now - Kalkine Media
Boston Scientific stock heads into the open after a 0.9% gain - ad-hoc-news.de
Boston Scientific stock holds steady as Oppenheimer cuts price target to USD 65 - ad-hoc-news.de
Oppenheimer Adjusts Price Target on Boston Scientific to $65 From $85, Maintains Outperform Rating - marketscreener.com
Boston Scientific stock holds steady as analysts weigh cyberattack impact - AD HOC NEWS
Citi downgrades Boston Scientific as cyberattack recovery compounds competitive pressure - MassDevice
Boston Scientific Shares Fall After Citigroup Downgrade - marketscreener.com
Boston Scientific (BSX) Stock Trades At A Discount On A 55% Slump - Yahoo Finance
Citi downgrades Boston Scientific on uncertain recovery path - Investing.com
Boston Scientific Can't Dislodge Rival's Heart Valve Patent - law360.com
TD Cowen maintains Boston Scientific stock rating after cyberattack - Investing.com
Citigroup Downgrades Boston Scientific to Neutral From Buy, Adjusts PT to $50 From $57 - marketscreener.com
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Boston Scientific: A Great Company At A Deeply Discounted Price (Rating Upgrade) - Seeking Alpha
Here’s How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years - Benzinga
Boston Scientific Leans on Acquisitions to Drive Long-Term Growth - finance.yahoo.com
Boston Scientific Corp Share PriceBSX, RNS News, Articles, Quotes, & Charts (NYSE:BSX) - Proactive financial news
Boston Scientific (BSX) Didn’t Miss on Demand or Devices. A Cyberattack Just Broke Its Guidance. - Yahoo Finance
Why Did BSX Cut FY26 Guidance? CEO Details Three Unanticipated Factors At Bernstein Conference - Stocktwits
Boston Scientific stock falls as cyberattack clouds 2026 outlook - ad-hoc-news.de
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Finance
Boston Scientific fully restores operations after cyberattack - Yahoo Finance
What Is Moving the Story Around Boston Scientific (BSX)? - Kalkine Media
Why Boston Scientific (BSX) Dipped More Than Broader Market Today - Yahoo Finance
Boston Scientific Corp (BSX) Stock Down 4.1% -- Now Undervalued? GF Score: 77/100 - GuruFocus
Boston Scientific Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Alpha Buying: 4 Falling Knives Insiders Are Buying - Benzinga
Boston Scientific stock falls as cyberattack clouds 2026 guidance - ad-hoc-news.de
Boston Scientific at Wells Fargo conference: cyberattack clouds outlook By Investing.com - Investing.com India
Boston Scientific at Wells Fargo conference: cyberattack clouds outlook - Investing.com
Boston Scientific Corp at Wells Fargo Healthcare Conference Transcript - GuruFocus
Update on recent cybersecurity incident - Boston Scientific
Boston Scientific stock falls as cyberattack prompts guidance cut and BTIG lowers price target - ad-hoc-news.de
Boston Scientific Corp Stock (BSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.65%
0.97%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):